Form 8-K FRACTYL HEALTH, INC. For: Jul 15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/20/2026
- Wall St futures edge higher ahead of this week's megacap earnings
- Oil reverses as Iranian comments interpreted as chance for fresh negotiations
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Medifast launches Trilivy, replacing its Optavia brand
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Adobe has received a takeover approach by a Big Tech company - Betaville
H.C. Wainwright Reiterates Buy Rating on Fractyl Health Inc (GUTS)
July 15, 2026 12:16 PM EDTH.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $8.00 price target on Fractyl Health Inc (NASDAQ: GUTS).
The analyst comments "Overall, we believe that REMAIN-1 midpoint cohort data demonstrate Revita-mediated durable and substantial weight retention at one year without the need for ongoing medication. We expect these observations to be reproduced and valudated in the ongoing, larger pivotal cohort of patients. Topline six-month randomized data are... More
